Diabetes Drugs

NEW YORK – A federal court in New York dismissed all but one claim against a pharmaceutical company in a suit claiming it inflated the prices of two diabetes drugs. The purchasers’ monopoly claims may continue, but their antitrust claims fail. 

%d bloggers like this: